Edwards Lifesciences (EW) Other Working Capital Changes (2016 - 2026)
Edwards Lifesciences has reported Other Working Capital Changes over the past 17 years, most recently at -$8.1 million for Q4 2025.
- For Q4 2025, Other Working Capital Changes fell 146.82% year-over-year to -$8.1 million; the TTM value through Dec 2025 reached $23.7 million, up 10.75%, while the annual FY2025 figure was $23.7 million, 10.75% up from the prior year.
- Other Working Capital Changes for Q4 2025 was -$8.1 million at Edwards Lifesciences, down from $28.5 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $72.3 million in Q4 2022 and troughed at -$33.2 million in Q3 2021.
- A 5-year average of $6.4 million and a median of $2.6 million in 2024 define the central range for Other Working Capital Changes.
- Biggest five-year swings in Other Working Capital Changes: plummeted 629.63% in 2023 and later surged 2950.0% in 2025.
- Year by year, Other Working Capital Changes stood at $20.0 million in 2021, then skyrocketed by 261.5% to $72.3 million in 2022, then plummeted by 104.43% to -$3.2 million in 2023, then skyrocketed by 640.62% to $17.3 million in 2024, then tumbled by 146.82% to -$8.1 million in 2025.
- Business Quant data shows Other Working Capital Changes for EW at -$8.1 million in Q4 2025, $28.5 million in Q3 2025, and $13.9 million in Q2 2025.